医学
疾病负担
疾病负担
环境卫生
公共卫生
疾病
人口学
全球卫生
潜在生命损失数年
糖尿病
质量调整寿命年
老年学
预期寿命
成本效益
人口
内科学
护理部
社会学
内分泌学
风险分析(工程)
作者
Ruyi Liang,Xiaobing Feng,Da Shi,Meng Yang,Linling Yu,Wei Liu,Min Zhou,Xing Wang,Weihong Qiu,Lieyang Fan,Bin Wang,Weihong Chen
摘要
Abstract Aims High fasting plasma glucose (HFPG) is an independent risk factor for several adverse health outcomes and has become a serious public health problem. We aimed to evaluate the spatial pattern and temporal trend of disease burden attributed to HFPG from 1990 to 2019 using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. Materials and Methods Using data from GBD 2019, we estimated the numbers and age‐standardized rates of deaths and disability‐adjusted life years (DALYs) attributed to HFPG by calendar year, age, gender, country, region, Socio‐demographic Index (SDI), and specific causes. The joinpoint regression analysis was used to assess the temporal trends of deaths and DALYs from 1990 to 2019. Results In 2019, globally, the numbers of deaths and DALYs attributable to HFPG were approximately 6.50 million and 172.07 million, respectively, with age‐standardized rates of 83.00 per 100,000 people and 2104.26 per 100,000 people, respectively. From 1990 to 2019, the global numbers of deaths and DALYs attributed to HFPG have over doubled. The age‐standardized rate of DALYs showed an increasing trend, particularly in males and in regions with middle SDI or below. The leading causes of the global disease burden attributable to HFPG in 2019 were diabetes mellitus, ischaemic heart disease, stroke, and chronic kidney disease. Conclusions HFPG is an important contributor to increasing the global and regional disease burden. Necessary measures should be taken to curb the growing burden attributed to HFPG, particularly in males and in regions with middle SDI or below.
科研通智能强力驱动
Strongly Powered by AbleSci AI